(Q37630869)

21 August 2017

1 reference

title

Inhibitors of type 2 sodium glucose co-transporters--a new strategy for diabetes treatment (English)

1 reference

21 August 2017

0 references

0 references

2

Bogusław Okopień

1 reference

21 August 2017

1

Aleksandra Bołdys

1 reference

21 August 2017

publication date

1 September 2009

1 reference

21 August 2017

published in

Pharmacological Reports

1 reference

21 August 2017

volume

61

1 reference

21 August 2017

issue

5

1 reference

21 August 2017

page(s)

778-784

1 reference

Type 2 diabetes mellitus: what is the optimal treatment regimen?

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970133-1

7 January 2021

Familial renal glucosuria: SLC5A2 mutation analysis and evidence of salt-wasting

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970133-1

7 January 2021

Intensive glycemic control in the ACCORD and ADVANCE trials

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970133-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970133-1

1 reference

7 January 2021

Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) inhibitors, exhibits antidiabetic efficacy in rodent models

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970133-1

7 January 2021

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970133-1

7 January 2021

Risk factors for symptomatic urinary tract infection in women with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970133-1

7 January 2021

Prevalence of clinical vaginal candidiasis in a university hospital and possible risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970133-1

7 January 2021

Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970133-1

7 January 2021

Sodium glucose co-transporter 2 inhibitors: blocking renal tubular reabsorption of glucose to improve glycaemic control in patients with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970133-1

7 January 2021

Normalization of blood glucose in diabetic rats with phlorizin treatment reverses insulin-resistant glucose transport in adipose cells without restoring glucose transporter gene expression.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970133-1

7 January 2021

The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970133-1

7 January 2021

Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970133-1

7 January 2021

Regulatory mechanisms of Na(+)/glucose cotransporters in renal proximal tubule cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970133-1

7 January 2021

Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970133-1

7 January 2021

Phlorizin prevents glomerular hyperfiltration but not hypertrophy in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970133-1

7 January 2021

Hypolipidemic drugs affect monocyte IL-1beta gene expression and release in patients with IIa and IIb dyslipidemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970133-1

7 January 2021

Inhibitor binding in the human renal low- and high-affinity Na+/glucose cotransporters

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970133-1

7 January 2021

Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970133-1

7 January 2021

Molecular Analysis of the SGLT2 Gene in Patients with Renal Glucosuria

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970133-1

7 January 2021

Autosomal recessive renal glucosuria attributable to a mutation in the sodium glucose cotransporter (SGLT2)

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970133-1

7 January 2021

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970133-1

7 January 2021

Active sugar transport in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2809%2970133-1

7 January 2021

10.1016/S1734-1140(09)70133-1

Identifiers

DOI

1 reference

21 August 2017

1 reference